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Asbestos and silica are well-known fibrogenic dusts. However, there is no comprehensive understanding of the molecular and cellular events that
lead to fibrosis as a consequence of asbestos or silica inhalation. Previous studies have shown that asbestos stimulates superoxide anion production
in alveolar macrophages through the phospholipase C/protein kinase C pathway. In contrast, silica does not appear to activate this pathway nor stimu-
late superoxide anion production, but silica does stimulate cytokine release by some undetermined pathway. Therefore, using human alveolar
macrophages isolated from normal healthy volunteers, we evaluated the potential involvement of intracellular calcium and tyrosine kinases as poten-
tial signal transduction pathways. In the absence of serum, crystalline silica, and to a lesser extent amorphous silica, caused a rapid and dose-depen-
dent elevation of intracellular calcium coming from the extracellular space. However, in the presence of serum, which is required for silica-stimulated
cytokine release, neither form of silica caused noticeable elevation of intracellular calcium. Silica, however, did increase the extent of tyrosine phos-
phorylation, most notably of proteins at approximately 46 and 50 kDa, suggesting activation of a tyrosine kinase pathway. Preincubation of alveolar
macrophages for 24 hr with silica-primed human alveolar macrophages for enhanced interleukin-10 (IL-1 3) release stimulated by endotoxin (LPS) that
was dose dependent. The enhanced LPS-stimulated release of IL-1i correlated with enhanced mitogen-activated protein kinase activity. Taken
together, these results indicate that a tyrosine kinase pathway is activated during silica stimulation of human alveolar macrophages. - Environ
Health Perspect 102(Suppl 10):69-74 (1994)
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Introduction
Ofall inhaled particulates, asbestos and sil-
ica are unique in their ability to cause lung
fibrosis. Both are recognized as ubiquitous
occupational fibrogenic agents, capable of
inducing fibroblast proliferation and excess
collagen production in the lung (1).
Although asbestos- and silica-induced lung
fibrosis are relatively well described on an
anatomic level, there is as yet no compre-
hensive understanding ofthe molecular and
cellular events that lead to fibrosis as a con-
sequence ofasbestos or silica inhalation.
The alveolar macrophage occupies a
key position in mediating the interaction
between inhaled particulates and other
lung cell types, such as lymphocytes and
fibroblasts. In addition to its abilities to
chemotax and phagocytose, the alveolar
macrophage produces a wide variety of
inflammatory and growth-mediating fac-
tors such as superoxide anion and
cytokines (2,3). The alveolar macrophage
This paper was presented at the Conference on
Oxygen Radicals and Lung Injury held 30 August-2
September 1993 in Morgantown, West Virginia.
This work was supported by National Institute of
Environmental Health Sciences Grant ES-04804 and
National Institutes of Health grant M01-RR-02558.
Address correspondence to Andrij Holian,
Department of Internal Medicine, The University of
Texas Medical School at Houston, 6431 Fannin
Street, Houston, TX 77225. Telephone (713) 794-
1205. Fax (713) 794-1741.
is therefore hypothesized to play a central
role in the development of particulate-
induced pulmonary fibrosis (4-6) through
the inappropriate release of effector mole-
cules with bioactivity for lung cells in
response to fibrogenic particulates.
Alveolar macrophages from animals
(7,8) and healthy human volunteers (9)
exposed to fibrogenic particulates in vitro
release factors that enhance fibroblast
growth. Consistent with these in vitro
observations, it has been shown that alveo-
lar macrophages recovered from animals
exposed to fibrogenic particulates (10) and
from individuals with interstitial lung dis-
ease (11) caused by asbestos, silica, or coal
dust appear to be in an activated state, as
reflected by their enhanced basal produc-
tion of cytokines such as interleukin-l1
(IL-15). A recent study indicates that basal
levels ofalveolar macrophage cytokine pro-
duction are also elevated in those human
subjects who have had extensive exposure
to asbestos but who have no evidence of
fibrosis (12). Macrophages from these lat-
ter subjects were found to release elevated
amounts of several effectors, including IL-
l,, tumor necrosis factor-a (TNF-a),
interleukin-6, granulocyte-macrophage
colonystimulating factor, and prostaglandin
E2 (12). Whether the release of these fac-
tors by alveolar macrophages exposed to
particulates in vivo is a result oftheir direct
interaction with the particulates, an indirect
result of the interaction of the particulates
with other lung cell types, or both, is not
known.
Previous in vitro studies using alveolar
macrophages isolated from guinea pigs and
humans demonstrated that while chrysotile
and crocidolite asbestos stimulate superox-
ide anion production, silica was not bioac-
tive for the release ofthis effector molecule
(13). Furthermore, the pathway for
asbestos stimulation ofalveolar macrophage
superoxide anion production involves the
phospholipase C/protein kinase C pathway
(14) and opening of verapamil-sensitive
calcium channels (15). In contrast, both
chrysotile and silica stimulated cytokine
release (e.g., TNF-ax and IL-15) indicating
either that the mechanism ofsilica stimula-
tion was distinct from chrysotile or that
chrysotile stimulated multiple pathways
(16).
Results from other laboratories using
rodent alveolar macrophages indicate that
silica can cause a marked elevation ofintra-
cellular calcium in vitro, implicating it as a
potential intracellular signal (17,18).
Therefore, in the present study we exam-
ined whether silica caused an elevation of
intracellular calcium in human alveolar
macrophages under similar conditions that
are required forcytokine release. In addition,
the potential involvement oftyrosine kinases
in silica stimulation was also evaluated.
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Materials and Methods
Particulates
Particulates for these studies included
chrysotile asbestos and silica, and the
nonfibrogenic particulate titanium dioxide.
Particulate concentrations were chosen to
represent equivalent surface areas. Unless
otherwise noted, particulates and their con-
centrations used in these studies were
Calidria asbestos RG-144 (Union Carbide,
King City, CA), natural length 1-5 pm, 25
pg/mi; crystalline silica, min-U-sil 5
(Pennsylvania Sand Glass Corp. Pittsburgh,
PA), 1-5 pm, 133 pg/ml; amorphous silica
(Sigma Chemical Co., St. Louis, MO), 1-3
pm, 80 pg/ml; and titanium dioxide
(Particle Information Services, Kingston,
WA), average particle diameter 0.45 pm, 60
pg/ml.
HumanAlveolarMacrophages
Cells for these experiments were obtained
by bronchoalveolar lavage of normal non-
smoking volunteers using methods described
previously (19). Typically, instillations of
240 to 300 ml of sterile saline resulted in
recoveries of200 to 260 ml oflavage fluid.
Cells were isolated from the lavage fluid as
described previously (13), and kept on ice
in HEPES-buffered Medium 199
(Whittaker Biochemicals, Walkersville,
MD) with or without 10% heat-inacti-
vated fetal calf serum (FCS, Sigma), at a
concentration of 1 x 106 cells/ml (ZBI,
Coulter Counter, Coulter Electronics,
Hialeah, FL) until use. Lavages yielded an
average of 107 cells that were >92%
macrophages as identified using Leukostat
(Fisher Scientific, Fairlawn, NJ) staining
and confirmed by esterase staining (20) of
cytocentrifuge preparations. Cells were
>85% viable byTrypan blue exclusion.
Intraceular CAcium
Cytosolic calcium concentrations were
monitored continuously using the fluores-
cent probe Fura-2, similar to that previ-
ously described (15). Macrophages
(10 /ml) were loaded for 30 min with 5
pM Fura-2 (Molecular Probes, Eugene,
OR) in Medium 199 at 25°C. The cells
were washed three times and resuspended
in the same medium. Cells were placed in a
continuously stirred cuvette with or with-
out 10% FCS at 37°C in a Photoelectron
Technology Inc. Delta Scanner dual wave-
length fluorimeter with excitation at 340
and 380 nm and emission at 511 nm.
Fluorescence intensities were continuously
recorded after addition of silica and stored
on a computer. The fluorescence data was
converted to calcium concentrations using
the equation (21):
[Calcium]i= Kd(F-FmIn(F -F),
where Kd = 224 nM, F= relative level of
intracellular fluorescence, Fmin = relative
level of fluorescence with 10 mM EGTA
after cell lysis with 0.1% Triton X-100,
and F = relative level of fluorescence in
the presence of4 mM calcium.
Cultures forIL-, Release
Cells (1 x106/ml) were cultured for 24 hr
in the presence or absence of 33 or 133
pg/ml silica in medium 199 with 10%
FCS. After 24 hr, lipopolysaccharide (LPS)
at 10 pg/mI or 100 ng/ml was added to
stimulate human alveolar macrophage IL-
13 release for 24 hr. Cells were maintained
in suspension by slow end-over-end tum-
bling in polypropylene tubes at 37°C.
Incubations were terminated by pelleting
the cells, and supernatants were frozen and
stored at -80°C until assayed. IL-13
released into the supernatants was quanti-
tated by EIA (Cayman Chemical, Ann
Arbor, MI).
ImmunoblottingforPhosphotyrosine
Cells were washed in phosphate-buffered
saline, denaturated and subjected to SDS
polyacrylamide gel electrophoresis.
Fractionated proteins were transfered to
nitrocellulose membranes by electroblot-
ting. Membranes were stained with 2%
Ponceau S (Sigma) to visualize protein
transfer to the membranes. Membranes
were incubated in blocking buffer (5%
nonfat dry milk, Tris-buffered saline with
sodium azide) for 16 hr at 4°C, and then
with antiphosphotyrosine monoclonal anti-
body (Upstate Biochemical Inc. (UBI),
Upstate, NY, clone 4G10) for 2 hr at room
temperature. The membranes were rinsed
with Tween 20 in Tris-buffered saline and
incubated with horseradish peroxidase-con-
jugated goat antimouse immunoglobulin G
(Amersham, Arlington Heights, IL) for 1
hr at room temperature. After rinsing with
Tween 20 in Tris-buffered saline, the anti-
body-antigen complex was visualized by
using enhanced chemiluminescence detec-
tion (Amersham) and byexposing the mem-
branes to ECL film (Amersham) for 1 min.
Mitogen-activated Protein (MAP)
KinaseActivity
The procedure was adapted from Clark-
Lewis et al. (22). At various times after
adding LPS, cells were solubilized for 30
min on ice in 50 mM Tris-150 mM saline
buffer, pH 8.0, containing 1% Nonidet P-
40, 1 mM EDTA, 100 pM sodium ortho-
vanadate, 1 pg/ml each of pepstatin and
leupeptin, 0.1% aprotinin, and 2 mM
phenylmethylsulfonyl fluoride. The solubi-
lized fraction was collected following cen-
trifugation and divided into two aliquots.
To the solubilized proteins, antihuman
MAP kinase (UBI) was added to a final
concentration of 1 pg/ml and incubated for
1 hr, then an equal volume of Protein A
agarose (10% suspension in the same
buffer) was added and incubated for
another hour. The agarose beads were
washed three times in the same buffer and
then used for the kinase assay. For the
kinase assay, 25 pl of reaction cocktail was
added to the agarose beads that consisted
of 2 mg/ml of MAP kinase substrate,
APRTPGGRR (UBI), 1 pM ATP with 2
pCi/sample of [y- P]ATP, 12.5 mM
MOPS (pH 7.2), 12.5 mM glycerol phos-
phate, 7.5 mM MgCl2, 0.5 mM EGTA,
0.05 mM NaF, 0.5 mM sodium ortho-
vanadate, and 2 mM dithiothreitol. The
reaction was allowed to proceed for 15 min
and stopped by spotting the entire contents
onto 2.1-cm circles of phosphocellulose
paper. The papers were washed seven times
with 1% phosphoric acid and the bound
radioactivity determined by liquid scintilla-
tion counting. Negative controls included
an irrelevant antibody.
Endotoxin
Endotoxin levels in buffers, media, and
particulate stock suspensions were assessed
by the Limulus amoebocyte assay (Sigma);
endotoxin levels were in all cases found to
be <20 pg/ml.
Statistics
Values are presented as the mean, and error
bars denote the standard error ofthe mean.
The number of individuals from whom
cells were obtained for a given experiment
is denoted by "N" in the corresponding
figure legend. For measurements of IL-i1 ,
statistical treatment was one-tailed paired
t-test.
Results
Silica-inducedChanges in
Intracellular Calium
Previous studies using rodent alveolar
macrophages have shown that silica can
cause an elevation in intracellular calcium
in vitro (17,18). Since elevation in intracel-
lular calcium could serve to signal down-
stream events, the effect of silica on
intracellular calcium in human alveolar
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macrophages using Fura-2 fluorescence was
examined. As shown in Figure 1, crys-
talline silica caused a rapid and sustained
elevation ofintracellular calcium. Addition
of67 or 133 jig/ml silica caused intracellu-
lar calcium to increase from a baseline of
approximately 150 nM to approximately
300 nM or almost 500 nM in approxi-
mately 9 min, respectively. In contrast,
intracellular calcium remained constant in
untreated cells. Furthermore, there was no
change in intracellular calcium following
silica addition to cells when 4 mM EDTA
was added just prior to silica, indicating
that the elevation of intracellular calcium
was dependent on extracellular sources of
calcium.
Similar results were obtained using
amorphous silica (Figure 2). Amorphorus
silica is generally considered less fibrogenic
than crystalline silica (23). Consistent with
decreased fibrogenic potential there was
decreased ability to elevate intracellular cal-
cium compared to crystalline silica when
given at approximately equal surface areas,
i.e., 40 and 80 pg/ml (to levels ofapproxi-
mately 200 and 300 nM over the same
time period, respectively). In addition, ele-
vation of intracellular calcium with amor-
phorous silica was also blocked using
EDTA and therefore dependent on extra-
cellular calcium.
The above experiments were conducted
in the absence of added serum. However,
in the absence of serum, silica does not
stimulate human alveolar macrophages to
release cytokines (data not shown). In the
presence of serum, silica stimulates the
release of a number of cytokines including
IL-1 (16). Therefore, the ability ofsilica to
elevate intracellular calcium under condi-
tions required for cytokine release were also
examined. As shown in Figure 3, neither
133 pg/ml crystalline nor 80 jig/ml amor-
phous silica caused noticable elevation of
intracellular calcium in the presence of
10% FCS.
Silica-inducedActivation of
IntracellularTyrosine Kinases
The above results suggest that under condi-
tions required for cytokine release silica
stimulation of human alveolar macro-
phages may proceed by a pathway indepen-
dent of changes in intracellular calcium.
Other studies indicated that silica also does
not cause noticable changes in cAMP or
cGMP levels (data not shown). However,
recent studies from other laboratories show
that tyrosine kinases are involved in endo-
toxin stimulation ofneutrophils and mito-
gen stimulation of lymphocytes (24,25).
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Figure 1. Effect of two doses of crystalline silica on intracellular calcium levels in human alveolar macrophages.
Intracellular calcium was measured as described in "Materials and Methods." The figure shows continuous
recordings of intracellular calcium for 133 pg/ml silica (1), 67 pg/ml silica (2), control (3), and 133 pg/ml silica with
4 mM EDTA-treated (4) cells. The arrow indicates the time of silica addition. The traces are representative ofthree
experiments.
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Figure 2. Effect of two doses of amorphous silica on intracellular calcium levels in human alveolar macrophages.
The figure shows continuous recordings of intracellular calcium for 80 pg/ml silica (1), 40 pg/ml silica (2), control
(3), and 80 pg/mI silica with 4 mM EDTA-treated (4) cells. The arrow indicates the time of silica addition. The
traces are representative ofthree experiments.
Therefore, the potential involvement of
tyrosine kinases in silica stimulation was
examined by Western blot analysis using
an antiphosphotyrosine antibody. Results
of phosphotyrosine Western blots are
shown for both 100 ng/ml LPS (Figure
4A) and 133 pg/ml crystalline silica (Figure
4B) stimulation of human alveolar
macrophages as a function of time. Both
LPS and silica caused rapid (<7.5 min)
increased phosphorylation of tyrosine
residues on specific proteins at approxi-
mately 46 and 80 kDa by LPS and 46 and
50 kDa by silica.
SilicaPrimningofHumanAlveolar
Macrophages
Preliminary studies in our laboratory sug-
gested that silica could prime alveolar
macrophages for an enhanced response to
LPS. Ofa number ofparticulates that were
examined, including chrysotile, titanium
dioxide, and amorphous silica (data not
shown), only crystalline silica was able to
prime human alveolar macrophages for
enhanced IL-1,8 release in response to LPS
stimulation, as shown in Figure 5. The
response was also dose dependent with silica
and LPS. Enhanced IL-15 release was
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Figure 3. Effect of serum on silica-induced elevation of intracellular calcium levels in human alveolar
macrophages. Cells were incubated in the presence of 10% serum prior to addition of silica. The figure shows con-
tinuous recordings of intracellular calcium for cells incubated with 133 pg/ml crystalline silica (1), or 80 pg/ml
amorphous silica (2), and the center trace is control. The arrow indicates the time of silica addition. The traces are
representative of two experiments.
for 24 hr then stimulated with 10 jig/ml
LPS.
To determine if the priming effect of
silica was associated with a potential tyro-
sine kinase pathway leading to cytokine
release, MAP kinase activity was measured
under similar conditions as described for
Figure 5. Macrophages were preincubated
30 60 CON for 24 hr with or without 33 pg/ml silica
then stimulated with 100 ng/ml LPS. At
various times after LPS stimulation, cells
were solubilized, MAP kinase was
immunoprecipitated and its activity quan-
titated. As shown in Figure 6, LPS stimu-
lated MAP kinase activity in a
time-dependent manner that peaked
around 15 min and returned to approxi-
mately basal levels around 60 min.
However, when cells were preincubaed
with silica, LPS stimulation resulted in
30 60 coN greater MAP kinase activity consistent with
30 60 CON the enhancedIL-153 production.
Figure 4. Tyrosine phosphorylation following endo-
toxin and crystalline silica stimulation of macrophages.
Tyrosine phosphoryaltion was detected as described in
"Materials and Methods" for macrophages stimulated
with (A) 100 ng/ml endotoxin (B) or 133 pg/ml silica.
The time of sampling is shown in minutes following
addition of either stimulant. The results are represen-
tative ofthree experiments.
slight, but significant, when cells were
preincubated with 33 pg/ml silica for 24 hr
then stimulated with 100 ng/ml LPS. The
results were more pronounced, and almost
reached significance (p= 0.05) when cells
were preincubated with 133 jig/ml silica
Discussion
Both silica and chrysotile asbestos stimulate
human alveolar macrophages. However,
while both particulates stimulate cytokine
release (16), only asbestos stimulates
superoxide anion production (13). These
observations imply that either asbestos
stimulates multiple pathways and one of
them is similar to that stimulated by silica,
or that the particulates stimulate indepen-
dent pathways. We have already described
that asbestos stimulates the phospholipase
C/protein kinase C pathway (14) and
opens a verapamil-sensitive calcium channel
in alveolar macrophages (15). Other inves-
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Figure 5. Endotoxin stimulation of IL-13 release from
control and silica-pretreated macrophages.
Macrophages were cultured for 24 hr without silica
(light bars) or with either of two different doses of sil-
ica (dark bars), washed and placed into fresh medium
and stimulated with endotoxin (100 ng/ml LPS with the
33 pg/ml silica dose or 10 pg/ml LPS with the 133
pg/mI silica dose). After 24 hr, supernatants were col-
lected and assayed for IL-1iB. The data are expressed
as the mean ± SE for n=7 at 133 pg/ml silica and n=6
for 33 pg/ml silica studies. Asterisk indicates p<0.05
for 33 pg/ml silica compared to control while at the
133 pg/ml dose of silica p=0.05.
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Figure 6. MAP kinase activityfollowing endotoxin stim-
ulation of control and silica-pretreated macrophages.
Culture conditions were identical to the 33 pg/ml silica-
treated cells described in Figure 5. After a 24-hr prein-
cubation with or without silica, 100 ng/ml of endotoxin
was added to untreated cells (o) or silica-treated cells
(0), and cells assayed for MAP kinase activity as
described in Materials and Methods. The data repre-
sentthe average oftwo values.
tigators using rodent alveolar macrophages
have demonstrated that silica can cause an
elevation of intracellular calcium (17,18).
Our results with human alveolar
macrophages are consistent with those
reports in that crystalline silica and, to a
lesser extent, amorphous silica can rapidly
cause elevation of intracellular calcium
(Figures 1, 2). Furthermore, the source of
the increase in intracellular calcium appears
to be from the extracellular pool, since it
could be blocked by removal ofextracellular
calcium. The mechanism bywhich calcium
enters macrophages is not certain, but may
involve the opening of calcium channels
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since preliminary experiments indicate that
it could be blocked by verapamil (unpub-
lished results).
Different results were obtained when
alveolar macrophages were incubated in the
presence of 10% FCS prior to the addition
ofsilica. In the presence ofserum, neither
form ofsilica was able to noticeably elevate
intracellular calcium (Figure 3). Although
silica may elevate intracellular calcium at a
later time point, there is a clear alteration
in bioactivity when serum is present, con-
sistent with previous obserations that the
bioactivity of silica (macrophage superox-
ide anion production) can be modified
significantly by addition of specific pro-
teins such as immunoglobulins and albu-
min (13). In addition, silica is more
cytotoxic in the absence of serum, consis-
tent with intracellular calcium changes in
these two conditions. Furthermore, within
this early time frame of approximately 10
min, silica was shown to stimulate intracel-
lular kinases in the presence of serum as
evidenced by the tyrosine phosphorylation
results (Figure 4). Therefore, silica can
cause signal transduction without an eleva-
tion ofintracellular calcium. Which model
(with or without serum) of macrophage
stimulation is more physiological is an
important consideration. While neither
one is ideal, the presence of certain serum
components (proteins and lipids) that may
mimic those present in the lung lining
fluid layer may be better than only a bal-
anced salt solution. Furthermore, we have
observed that silica-stimulated cytokine
release (e.g., IL-1v and TNF-ac) from
human alveolar macrophages is much
greater in the presence ofserum.
Recent studies show that other cells
such as lymphocytes can be stimulated by a
tyrosine kinase-mediated pathway (24,25).
Our results suggest that silica may stimu-
late human alveolar macrophages through
such a pathway (Figure 4). We observed
increased tyrosine phosphorylation follow-
ing either LPS or silica stimulation of a
number of proteins, most notably at 46
and 80 kDa with LPS and 46 and 50 kDa
with silica. Although these proteins remain
to be identified, it maybe speculated that the
46-kDa protein is a MAP kinase isoform.
Our results also show that a 24-hr
preincubation with silica can prime human
alveolar macrophages for enhanced release
of IL-15 in response to LPS (Figure 5).
The effect was observed using low doses of
silica and LPS and was pronounced with
high doses of both silica and LPS.
Consistent with the implication for the
involvement oftyrosine phosphorylation in
silica stimulation, MAP kinase activity was
also enhanced following silica priming and
correlated with the enhanced cytokine
release. Therefore, silica can upregulate
macrophages by some mechanism that
results in increased MAP kinase activity
and cytokine release to a second stimulus
such as LPS. These results raise the possi-
bility that bacterial infections could play
some role in fibrogenesis.
In summary, silica increases intracellu-
lar calcium in a balanced salt solution
medium. However, in the presence of 10%
serum, which appears to be required for
cytokine release, silica does not increase
intracellular calcium levels. Silica by itself
does stimulate tyrosine phosphorylation as
well as prime macrophages for enhanced
MAP kinase activity and cytokine release in
response to a second stimulus such as LPS.
Taken together, these results suggest that
silica activates and modifies a tyrosine
kinase pathway in human alveolar
macrophages that may be important in the
development offibrosis.
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